Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChAdOx1 Chik in healthy volunteers
NCT03590392Phase 1Completed
- Sponsor
- University of Oxford
- Start
- Jul 2018
- Primary completion
- Sep 2019
- Modality
- Prophylactic Vaccines, Adenoviral Vectors, DNA Vaccines
- Countries
- 1
01
Overview
Phase 1, open-label trial of ChAdOx1 Chik in chikungunya fever (CHIKV) (3 arms), sponsored by University of Oxford. Primary endpoint: Occurrence of solicited and unsolicited local and systemic adverse events at 6 months. Started Jul 2018; status: completed.
02
Drugs
ChAdOx1 Chik
03
Conditions
chikungunya fever (CHIKV)
Beyond the preview
Go deeper on NCT03590392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03590392.